Skip to main content
UniHealth

Doctor search

Rosendo So-Rosillo, MD

Hematology/Oncology · Redwood City

NPI 1407889827

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
4
1 carrier
Office
1

Offices

1 location · Permanente Medical Group Inc · 10,928 clinicians in this group

Looking this up.

Hospitals listed: 051589. That is not proof they admit you there this week.

Plans that list them

4 plans · 1 carrier

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. So-Rosillo’s office at (650) 299-2000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

Plans whose provider directory lists this clinician
Kaiser Permanente Dual Complete North P2 (HMO D-SNP)Kaiser PermanenteListedSep 1, 2026
Kaiser Permanente Dual Complete North P23 (HMO D-SNP)Kaiser PermanenteListedSep 1, 2026
Kaiser Permanente Sr Adv Basic Santa Clara (HMO)Kaiser PermanenteListedSep 1, 2026
Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO)Kaiser PermanenteListedSep 1, 2026

California Medical Board record

Licence A81804 · Current

Licensed to practise in California · since 2003 · expires 2026-10-31 · University of California, Los Angeles School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Drugs they prescribed that Part D paid

$2,842,206

Pharmacies billed $2,842,206 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 4% of their Part D prescriptions (55 of 1,260) in 2024. At or below the middle of the specialty; the typical hematology-oncology clinician is at 5%.

976 generic and fewer than 11 brand-name prescriptions · $2,842,206 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Xtandi50$609,911$12,198
Lynparza18$285,520$15,862
Inlyta17$260,855$15,344
Lenvima11$231,389$21,035
Erleada12$194,488$16,207
See all 27 drugs
Every Part D drug this clinician prescribed
Xtandi50$609,911$12,198
Lynparza18$285,520$15,862
Inlyta17$260,855$15,344
Lenvima11$231,389$21,035
Erleada12$194,488$16,207
Kisqali13$177,218$13,632
Brukinsa12$157,533$13,128
Calquence14$150,937$10,781
Abiraterone Acetate243$59,760$246
Nivestym55$36,461$663
Orgovyx11$28,468$2,588
Granix26$18,971$730
Hydroxyurea56$2,335$42
Anastrozole77$2,247$29
Prednisone207$1,846$9
Dexamethasone39$827$21
Potassium Chloride27$615$23
Hydrocodone-Acetaminophen24$518$22
Oxycodone25$450$18
Bicalutamide13$431$33
Methylphenidate11$326$30
Ondansetron37$292$8
Lidocaine-Prilocaine15$240$16
Hydrocortisone12$215$18
Ondansetron Odt17$207$12
Prochlorperazine Maleate12$201$17
Famotidine17$144$8

Year by year

Part D prescribing by year
20241,2602004% (55)None$2,842,206
20231,1861853% (36)None$3,188,883
20221,1241764% (40)None$3,322,464
20211,1081693% (37)28%$3,332,626
20201,0001695% (54)31%$3,269,686
20191,0381835% (56)30%$3,042,654
20189431793% (28)None$2,701,526
20171,0031906% (56)29%$1,846,805
201673817210% (71)None$1,407,267
20156701819% (58)21%$756,244
20147921117% (56)None$459,235
201367111310% (69)10%$228,596

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 21 drugs

Part D drugs prescribed in 2023
Xtandi49$563,665$11,503
Erleada22$338,003$15,364
Lenalidomide21$324,665$15,460
Lenvima16$321,176$20,074
Lynparza28$296,440$10,587
Inlyta14$260,033$18,574
Calquence16$163,626$10,227
Brukinsa12$150,920$12,577
Sprycel12$149,388$12,449
Imbruvica13$86,424$6,648
Nivestym80$55,065$688
Abiraterone Acetate177$48,358$273
Hydroxyurea58$2,408$42
Anastrozole71$1,928$27
Prednisone184$1,781$10
Dexamethasone43$1,075$25
Hydrocodone-Acetaminophen25$486$19
Ondansetron52$482$9
Potassium Chloride23$475$21
Levothyroxine12$171$14
Famotidine19$157$8

2022: 23 drugs

Part D drugs prescribed in 2022
Xtandi50$508,909$10,178
Erleada21$307,707$14,653
Revlimid20$287,236$14,362
Lynparza29$284,991$9,827
Lenalidomide20$279,550$13,977
Alunbrig12$264,035$22,003
Cabometyx11$166,486$15,135
Brukinsa12$151,988$12,666
Ibrance11$144,695$13,154
Imbruvica11$68,876$6,261
Abiraterone Acetate211$44,068$209
Zarxio52$32,986$634
Nivestym24$12,990$541
Hydroxyurea49$2,788$57
Anastrozole66$1,688$26
Prednisone143$1,535$11
Dexamethasone27$1,320$49
Bicalutamide33$632$19
Hydrocodone-Acetaminophen30$558$19
Ondansetron32$327$10
Duloxetine13$248$19
Lidocaine-Prilocaine11$185$17
Famotidine12$84$7

2021: 23 drugs

Part D drugs prescribed in 2021
Revlimid56$987,369$17,632
Xtandi52$509,136$9,791
Ibrance26$327,207$12,585
Erleada21$292,829$13,944
Imbruvica20$210,133$10,507
Alecensa12$207,116$17,260
Sprycel11$166,516$15,138
Zarxio55$40,483$736
Abiraterone Acetate176$31,689$180
Prednisone122$2,775$23
Hydroxyurea51$2,774$54
Dexamethasone43$2,164$50
Anastrozole71$1,829$26
Bicalutamide41$1,011$25
Entecavir12$491$41
Hydrocodone-Acetaminophen23$490$21
Ondansetron33$399$12
Letrozole14$347$25
Acyclovir13$310$24
Lidocaine-Prilocaine12$307$26
Prochlorperazine Maleate14$305$22
Methylphenidate16$208$13
Ondansetron Odt12$137$11

2020: 25 drugs

Part D drugs prescribed in 2020
Revlimid63$1,152,147$18,288
Xtandi65$633,324$9,743
Erleada21$279,409$13,305
Ibrance21$268,916$12,806
Alecensa13$217,888$16,761
Imbruvica15$175,324$11,688
Sprycel12$173,021$14,418
Zarxio31$56,843$1,834
Abiraterone Acetate87$26,634$306
Dexamethasone56$3,256$58
Imatinib Mesylate14$3,153$225
Hydroxyurea52$2,669$51
Anastrozole72$1,821$25
Prednisone95$1,559$16
Acyclovir29$715$25
Hydrocodone-Acetaminophen34$683$20
Bicalutamide27$494$18
Letrozole18$445$25
Lidocaine-Prilocaine16$370$23
Ondansetron Odt11$255$23
Prochlorperazine Maleate11$231$21
Oxycodone11$174$16
Ondansetron15$133$9
Alendronate12$125$10
Montelukast11$85$8

2019: 27 drugs

Part D drugs prescribed in 2019
Revlimid55$1,005,538$18,283
Xtandi63$585,058$9,287
Erleada15$190,295$12,686
Imbruvica16$187,923$11,745
Tagrisso12$185,019$15,418
Sprycel17$184,529$10,855
Votrient13$164,729$12,671
Abiraterone Acetate77$138,350$1,797
Zarxio41$51,591$1,258
Xarelto12$5,447$454
Imatinib Mesylate15$4,461$297
Dexamethasone53$3,418$64
Prednisone122$2,040$17
Hydroxyurea42$1,970$47
Anastrozole70$1,749$25
Tenofovir Disoproxil11$990$90
Hydrocodone-Acetaminophen46$602$13
Bicalutamide26$552$21
Methylphenidate17$461$27
Acyclovir28$420$15
Letrozole17$418$25
Ondansetron Odt12$273$23
Lidocaine-Prilocaine15$266$18
Prochlorperazine Maleate15$260$17
Ondansetron20$174$9
Lorazepam14$116$8
Famotidine11$95$9

2018: 20 drugs

Part D drugs prescribed in 2018
Xtandi84$688,552$8,197
Zytiga58$600,717$10,357
Revlimid24$337,750$14,073
Tagrisso15$238,770$15,918
Pomalyst13$208,181$16,014
Votrient19$180,678$9,509
Zarxio27$32,910$1,219
Tenofovir Disoproxil23$11,745$511
Dexamethasone72$3,789$53
Anastrozole98$2,631$27
Hydroxyurea39$2,507$64
Prednisone92$1,707$19
Bicalutamide40$1,267$32
Letrozole18$452$25
Ondansetron28$382$14
Acyclovir16$325$20
Methylphenidate12$320$27
Hydrocodone-Acetaminophen22$260$12
Venlafaxine11$221$20
Lidocaine Hcl Viscous13$190$15

2017: 30 drugs

Part D drugs prescribed in 2017
Xtandi60$591,008$9,850
Zytiga39$367,871$9,433
Revlimid21$240,249$11,440
Pomalyst12$186,935$15,578
Iressa23$165,238$7,184
Tarceva11$94,013$8,547
Viread34$51,912$1,527
Zarxio14$23,856$1,704
Pradaxa17$4,327$255
Anastrozole93$2,697$29
Hydroxyurea26$1,973$76
Megestrol Acetate34$1,849$54
Potassium Chloride13$1,823$140
Bicalutamide34$1,553$46
Prednisone76$1,482$20
Dexamethasone69$1,338$19
Lidocaine-Prilocaine14$1,039$74
Hydrocodone-Acetaminophen26$746$29
Ondansetron Odt16$700$44
Tamoxifen Citrate13$680$52
Acyclovir32$593$19
Morphine Sulfate Er12$494$41
Letrozole17$460$27
Ondansetron18$305$17
Nystatin19$252$13
Methylphenidate14$251$18
Sulfamethoxazole-Trimethoprim13$218$17
Lorazepam20$191$10
Prochlorperazine Maleate14$162$12
Alendronate11$156$14

2016: 18 drugs

Part D drugs prescribed in 2016
Xtandi67$605,949$9,044
Zytiga31$273,936$8,837
Zarxio12$23,027$1,919
Viread11$14,335$1,303
Pradaxa28$4,509$161
Hydroxyurea19$1,592$84
Hydrocodone-Acetaminophen38$1,460$38
Anastrozole43$1,460$34
Bicalutamide42$1,453$35
Megestrol Acetate16$1,145$72
Prednisone47$1,035$22
Dexamethasone46$851$18
Acyclovir33$770$23
Morphine Sulfate Er14$663$47
Ondansetron16$283$18
Lorazepam18$174$10
Sulfamethoxazole-Trimethoprim11$161$15
Famotidine11$114$10

2015: 16 drugs

Part D drugs prescribed in 2015
Xtandi40$342,600$8,565
Neupogen12$18,376$1,531
Hydrocodone-Acetaminophen23$2,086$91
Hydroxyurea31$1,565$50
Letrozole28$1,418$51
Morphine Sulfate Er16$1,215$76
Bicalutamide42$1,080$26
Anastrozole68$1,039$15
Megestrol Acetate12$985$82
Tamoxifen Citrate12$655$55
Acyclovir24$343$14
Dexamethasone23$315$14
Ondansetron16$305$19
Lorazepam31$246$8
Prednisone22$210$10
Sulfamethoxazole-Trimethoprim11$206$19

2014: 21 drugs

Part D drugs prescribed in 2014
Sprycel16$151,165$9,448
Xtandi13$109,837$8,449
Letrozole84$3,959$47
Hydroxyurea54$2,177$40
Fentanyl12$1,619$135
Anastrozole73$1,268$17
Clarithromycin12$1,077$90
Tamoxifen Citrate26$851$33
Hydrocodone-Acetaminophen18$668$37
Acyclovir43$664$15
Bicalutamide29$653$23
Oxycodone13$546$42
Prochlorperazine Maleate31$289$9
Dexamethasone30$222$7
Zolpidem23$217$9
Gabapentin14$209$15
Lorazepam38$198$5
Ondansetron15$185$12
Prednisone22$146$7
Omeprazole13$138$11
Paroxetine11$44$4

2013: 19 drugs

Part D drugs prescribed in 2013
Pomalyst11$117,799$10,709
Letrozole56$5,574$100
Hydroxyurea65$3,122$48
Fentanyl15$2,889$193
Clarithromycin12$2,375$198
Anastrozole53$1,866$35
Megestrol Acetate11$812$74
Acyclovir30$772$26
Tamoxifen Citrate22$526$24
Oxycodone13$486$37
Hydrocodone-Acetaminophen18$365$20
Prochlorperazine Maleate29$332$11
Levofloxacin19$294$15
Ondansetron11$205$19
Dexamethasone21$173$8
Warfarin14$155$11
Lorazepam25$153$6
Prednisone35$125$4
Zolpidem13$106$8

Money from drug and device companies

$115 in 2019

A payment is not proof that care is biased.

Payments by company
E.R. Squibb & Sons L.L.C.Empliciti$115
1 payment
  • Meals for Empliciti · 2019-02-26 · $115
See the published payment
Every published payment
E.R. Squibb & Sons L.L.C.Meals · 2019-02-26Empliciti$115

Professional record

NPI
1407889827
Licence
CA A81804California A81804: Current · expires 2026-10-31
Trained
University of California, Geffen School of Medicine, 1997
Gender
Male
More record details
Sole proprietor
No
Taxonomy
Medical oncology (207RX0202X); Internal medicine (207R00000X)
Mailing address
2350 W El Camino Real, 2nd Floor, Mountain View, CA, 94040
NPI first listed
2006-07-09
NPI last updated
2021-12-15

This is when the NPI record was last certified, not a medical board exam.

This office lists an electronic records connection.